Robert Hamilton Pierce

Insider Reports History

Location
Rockville, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Hamilton Pierce:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. Chief R&D Officer Common Stock 94,463 $80,294 $0.8500 15 Feb 2022 Direct

Insider Reports Filed by Robert Hamilton Pierce

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2022 0 $0 4/A Chief R&D Officer 01 Sep 2022, 16:57
SNSE Sensei Biotherapeutics, Inc. 11 Aug 2021 1 -$117,718 4 Chief Scientific Officer 12 Aug 2021, 17:07
SNSE Sensei Biotherapeutics, Inc. 06 Aug 2021 3 -$568,246 4 Chief Scientific Officer 10 Aug 2021, 17:40
SNSE Sensei Biotherapeutics, Inc. 03 Feb 2021 0 $0 3/A Chief Scientific Officer 10 Aug 2021, 17:38